The inadequate anti-tumour necrosis factor (anti-TNF) therapy in patients with ankylosing spondylitis

被引：0
|
作者：
Borman, Pinar [1 ]
Ayhan, Figen [1 ]
Ceceli, Esma [1 ]
机构：
[1] Ankara Numune Training & Res Hosp, Clin PMR, Ankara, Turkey
来源：
RHEUMATOLOGY INTERNATIONAL | 2010年 / 30卷 / 12期
关键词：
Ankylose Spondylitis; High Disease Activity; Physical Therapy Intervention; Outpatient Unit; Rheumatology Outpatient;
D O I：
10.1007/s00296-009-1283-y
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1689 / 1690
页数：2
相关论文
共 50 条
  • [1] The inadequate anti-tumour necrosis factor (anti-TNF) therapy in patients with ankylosing spondylitis
    Pinar Borman
    Figen Ayhan
    Esma Ceceli
    Rheumatology International, 2010, 30 : 1689 - 1690
  • [2] The unmet need for anti-tumour necrosis factor (anti-TNF) therapy in ankylosing spondylitis
    Barkham, N
    Kong, KO
    Tennant, A
    Fraser, A
    Hensor, E
    Keenan, AM
    Emery, P
    RHEUMATOLOGY, 2005, 44 (10) : 1277 - 1281
  • [3] Anti-tumour necrosis factor a therapy for ankylosing spondylitis: international experience
    Braun, J
    Sieper, J
    Breban, M
    Collantes-Estevez, E
    Davis, J
    Inman, R
    Marzo-Ortega, H
    Mielants, H
    ANNALS OF THE RHEUMATIC DISEASES, 2002, 61 : 51 - 60
  • [4] Anti-tumour necrosis factor therapy for ankylosing spondylitis - unresolved issues
    Jois, R. N.
    Gaffney, K.
    Keat, A.
    RHEUMATOLOGY, 2007, 46 (06) : 899 - 901
  • [5] ANKYLOSING SPONDYLITIS: ANTI-TUMOUR NECROSIS FACTOR AND BEYOND
    Sengupta, Raj
    RHEUMATOLOGY, 2017, 56 : 10 - 10
  • [6] BASDAI CHANGES IN ANKYLOSING SPONDYLITIS PATIENTS TREATED WITH ANTI-TUMOUR NECROSIS FACTOR THERAPY
    Clarke, Laura
    Kay, Lesley
    RHEUMATOLOGY, 2010, 49 : I58 - I59
  • [7] Anti-tumour necrosis factor therapy in ankylosing spondylitis. A need for guidelines
    Kassimos, DG
    Garyfallos, A
    Delamere, J
    Whallett, A
    Kitas, GD
    RHEUMATOLOGY, 2003, 42 (03) : 490 - 490
  • [8] Immunogenicity of anti-tumour necrosis factor therapy in Korean patients with rheumatoid arthritis and ankylosing spondylitis
    Jung, Seung Min
    Kim, Hyun-Sook
    Kim, Hae-Rim
    Kim, Na Young
    Lee, Jung-Hwa
    Kim, Juryun
    Kwok, Seung-Ki
    Park, Kyung-Su
    Park, Sung-Hwan
    Kim, Ho-Youn
    Ju, Ji Hyeon
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2014, 21 (01) : 20 - 25
  • [9] TREATMENT SATISFACTION WITH TUMOUR NECROSIS FACTOR-ALPHA INHIBITORS (ANTI-TNF) IN ANKYLOSING SPONDYLITIS
    Oksuzi, M. F.
    Balci, M. A.
    Tufan, A. N.
    Sahin, A. B.
    Gocken, A.
    Durmus, Y.
    Donmez, S.
    Dalkilic, E.
    Pamuk, O. N.
    Pehlivan, Y.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 1149 - 1149
  • [10] Anti-tumour necrosis factor (TNF)-α therapy (etanercept)
    Maya Buch
    Arthritis Research & Therapy, 4 (1)
12345